These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 8354028)

  • 1. Influence of cyclosporine pharmacokinetics, trough concentrations, and AUC monitoring on outcome after kidney transplantation.
    Lindholm A; Kahan BD
    Clin Pharmacol Ther; 1993 Aug; 54(2):205-18. PubMed ID: 8354028
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Posttransplant day significantly influences pharmacokinetics of cyclosporine after hematopoietic stem cell transplantation.
    Jacobson PA; Ng J; Green KG; Rogosheske J; Brundage R
    Biol Blood Marrow Transplant; 2003 May; 9(5):304-11. PubMed ID: 12766880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of oral cyclosporine (Neoral) in heart transplant recipients during the immediate period after surgery.
    Banner NR; David OJ; Leaver N; Davis J; Breen J; Johnston A; Yacoub MH
    Transpl Int; 2002 Dec; 15(12):649-54. PubMed ID: 12478413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A comparative randomized prospective multicenter study of Sandimmune vs Neoral in liver transplantation].
    Roy A; Grant DR; Kneteman NM; Tchervenkov JI; Levy GA; Tan A; Hendricks L
    Ann Chir; 1998; 52(8):716-21. PubMed ID: 9846420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The adverse impact of high cyclosporine. Clearance rates on the incidences of acute rejection and graft loss.
    Lindholm A; Welsh M; Rutzky L; Kahan BD
    Transplantation; 1993 May; 55(5):985-93. PubMed ID: 8497912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of changing from cyclosporine C0 to C2 monitoring in stable recipients following renal transplantation: a prospective cohort study.
    Zhang Y; Zhang XD; Wang Y
    Transplant Proc; 2011 Dec; 43(10):3697-701. PubMed ID: 22172829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is 3-hour cyclosporine blood level superior to trough level in early post-renal transplantation period?
    Mahalati K; Lawen J; Kiberd B; Belitsky P
    J Urol; 2000 Jan; 163(1):37-41. PubMed ID: 10604309
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Study of cyclosporine level at 2 hours after administration in preoperative kidney transplant recipients for prediction of postoperative optimal cyclosporine dose.
    Sukhavasharin N; Praditpornsilpa K; Avihingsanon Y; Kuoatawintu P; O-Charoen R; Kansanabuch T; Tungsanga K; Eiam-Ong S
    J Med Assoc Thai; 2006 Aug; 89 Suppl 2():S15-20. PubMed ID: 17044449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiac allograft rejection: do trough cyclosporine levels correlate with the grade of histologic rejection?
    el Gamel A; Keevil B; Rahman A; Campbell C; Deiraniya A; Yonan N
    J Heart Lung Transplant; 1997 Mar; 16(3):268-74. PubMed ID: 9087869
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclosporine microemulsion increases drug exposure and reduces acute rejection without incremental toxicity in de novo renal transplantation. International Sandimmun Neoral Study Group.
    Keown P; Niese D
    Kidney Int; 1998 Sep; 54(3):938-44. PubMed ID: 9734620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Demographic factors influencing cyclosporine pharmacokinetic parameters in patients with uremia: racial differences in bioavailability.
    Lindholm A; Welsh M; Alton C; Kahan BD
    Clin Pharmacol Ther; 1992 Oct; 52(4):359-71. PubMed ID: 1330397
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Time-dependent changes in cyclosporine exposure: implications for achieving target concentrations.
    Felipe CR; Silva HT; Machado PG; Garcia R; Moreira SR; Pestana JO
    Transpl Int; 2003 Jul; 16(7):494-503. PubMed ID: 12677364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of cyclosporine in monkeys after oral and intramuscular administration: relation to efficacy in kidney allografting.
    Schuurman HJ; Slingerland W; Mennninger K; Ossevoort M; Hengy JC; Dorobek B; Vonderscher J; Ringers J; Odeh M; Jonker M
    Transpl Int; 2001 Sep; 14(5):320-8. PubMed ID: 11692216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of clinical events with everolimus exposure in kidney transplant patients receiving reduced cyclosporine.
    Shihab FS; Cibrik D; Chan L; Kim YS; Carmellini M; Walker R; Zibari G; Pattison J; Cornu-Artis C; Wang Z; Tedesco-Silva H
    Clin Transplant; 2013; 27(2):217-26. PubMed ID: 23230975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics and Long-Term Safety and Tolerability of Everolimus in Renal Transplant Recipients Converted From Cyclosporine.
    Felipe CR; Oliveira NI; Hannun PG; de Paula MI; Tedesco-Silva H; Medina-Pestana JO
    Ther Drug Monit; 2016 Feb; 38(1):64-72. PubMed ID: 26274696
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An economic model of 2-hour post-dose ciclosporin monitoring in renal transplantation.
    Keown PA; Kiberd B; Balshaw R; Khorasheh S; Marra C; Belitsky P; Kalo Z
    Pharmacoeconomics; 2004; 22(10):621-32. PubMed ID: 15244488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclosporine monitoring in the early post-transplant period in pediatric liver transplant recipients.
    Frauca E; Diaz MC; de la Vega A; Hierro L; Camarena C; Muñoz Bartolo G; Díez R; Murcia J; Gámez M; Sanchez Peinado C; López Santamaría M; Andrés I; Jara P
    Pediatr Transplant; 2007 Aug; 11(5):530-5. PubMed ID: 17631022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blood cyclosporine level soon after kidney transplantation is a major determinant of rejection: insights from the Mycophenolate Steroid-Sparing Trial.
    Gotti E; Perico N; Gaspari F; Cattaneo D; Lesti MD; Ruggenenti P; Segoloni G; Salvadori M; Rigotti P; Valente U; Donati D; Sandrini S; Federico S; Sparacino V; Mourad G; Bosmans JL; Dimitrov BD; Iordache BE; Remuzzi G
    Transplant Proc; 2005 Jun; 37(5):2037-40. PubMed ID: 15964332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between cyclosporine concentrations at 2 hours post-dose and clinical outcomes in de novo lung transplant recipients.
    Akhlaghi F; Gonzalez L; Trull AK
    J Heart Lung Transplant; 2005 Dec; 24(12):2120-8. PubMed ID: 16364860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetic strategies for cyclosporin therapy in organ transplantation.
    Kahan BD; Welsh M; Knight R; Katz S; Lewis R; Grevel J; Van Buren CT
    J Autoimmun; 1992 Apr; 5 Suppl A():333-41. PubMed ID: 1503629
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.